Every PMCPA ruling since 2005 — searchable and filterable by company, clause, and ABPI Code version.
Case Library Membership
Search free — but unlock advanced filters to find every case involving a specific company or clause.
Already a member? Sign in →
Case Library Membership
inc. VAT
inc. VAT · cancel any time
Secure payment via Stripe
Need access for your team?
Company licences available for compliance teams, medical affairs, and training programmes.
Get a team quote →1,930 cases found
Complaint alleged Jemperli HCP webpages weren’t properly certified for mobile due to layout/navigation differences and that a “manageable safety profile” claim was…
PMCPA found Pfizer in breach after a UK employee ‘liked/loved’ two NHS LinkedIn posts naming voxelotor and making benefit claims. The original…
Third‑party publisher email implied an unbiased ESMO update but linked to a page integrating Novartis Pluvicto promotion. UK HCPs saw EU SmPC/indication,…
Complaint alleged a senior employee’s LinkedIn ‘Experience’ section promoted Enhertu to the public and off-label, using terms like “blockbuster” and “new”. Panel…
A third‑party medical publication email drove HCPs to a webpage containing Gilead‑sponsored content, but the email didn’t declare Gilead’s involvement upfront. Breach…
Complaint alleged Idorsia promoted Quviviq to the public by redirecting “public” users to eMC and that “NICE recommended for chronic insomnia” was…
Pfizer UK’s 2020 Twitter thread on Phase 3 Covid-19 vaccine results (plus linked BioNTech content and press release) was ruled promotional before…
A third-party publisher sent an EU-focused Pluvicto promo email to UK HCPs after a “Europe” targeting error. Panel found disguised promotion, unclear…
Complaint alleged Roche funding wasn’t declared “from the outset” on patient organisation programme webpages/materials. Panel found complainant hadn’t shown Roche funded the…
Complaint alleged a third‑party promotional email for Xarelto omitted contraindications/special warnings (renal impairment) and breached a prior undertaking. PMCPA Panel ruled no…
Third‑party publisher sent repeated Bavencio promotional emails. Panel found promotion was disguised (sender/subject line and poor prominence of sponsorship) and frequency lacked…
AbbVie failed to recertify an AbbVie Pro “Oncology Focus Area” landing page within the required two-year interval. PMCPA found a breach of…
PMCPA found Moderna responsible for a senior employee’s policy articles and X reposts. Missing disclosure breached Clause 5.5 and high standards (5.1).…
Theramex’s LinkedIn ‘About Us’ described its solutions as “innovative, effective and safe”. The PMCPA ruled this was misleading and used ‘safe’ without…
Ex-contractor alleged GSK hospital reps duplicated/falsified CRM call records and management knew. Referee said call frequency aspect was in scope, but Panel…
Our PMCPA rulings expert has knowledge of over 1,900 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.
